Nektar Therapeutics (NKTR): Price and Financial Metrics

Nektar Therapeutics (NKTR)

Today's Latest Price: $20.02 USD

0.28 (-1.38%)

Updated Dec 5 2:32pm

Add NKTR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 326 in Biotech

See all "A" rated Strong Buy stocks

NKTR Stock Summary

  • Of note is the ratio of Nektar Therapeutics's sales and general administrative expense to its total operating expenses; merely 7.8% of US stocks have a lower such ratio.
  • NKTR's price/sales ratio is 27.18; that's higher than the P/S ratio of 96.04% of US stocks.
  • Revenue growth over the past 12 months for Nektar Therapeutics comes in at -91.33%, a number that bests merely 0.79% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Nektar Therapeutics, a group of peers worth examining would be NVAX, MGNX, ARDS, UMRX, and INO.
  • Visit NKTR's SEC page to see the company's official filings. To visit the company's web site, go to
NKTR Daily Price Range
NKTR 52-Week Price Range

NKTR Stock Price Chart More Charts

NKTR Price/Volume Stats

Current price $20.02
Prev. close $20.30
Day low $19.83
Day high $20.50
50-day MA $18.47
200-day MA $27.39
52-week high $47.11
52-week low $15.64
Volume 943,499
Avg. volume 2,412,698
Dividend yield N/A
Market Cap 3.52B

Nektar Therapeutics (NKTR) Company Bio

Nektar Therapeutics is a biopharmaceutical company, developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.

NKTR Latest News Stream

Event/Time News Detail
Loading, please wait...

NKTR Latest Social Stream

Loading social stream, please wait...

View Full NKTR Social Stream

NKTR Price Returns

1-mo 7.98%
3-mo 17.70%
6-mo -39.33%
1-year N/A
3-year 59.02%
5-year 23.28%
YTD -39.09%
2018 -44.96%
2017 386.72%
2016 -27.18%
2015 8.71%
2014 36.56%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9583 seconds.